News

About one-third of Canadians have become obese — with more weight gain happening during the pandemic, according to a new ...
SINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious ...
New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...
Tribune Content Agency on MSN5h
Animal Doctor: The Obese Pet Issue
FOX: We have two black Labrador retrievers, ages 3 and 4. We wonder if there will soon be injections available for overweight dogs, similar to Wegovy and Ozempic for humans.-- W.M., South Bend, ...
Danish pharmaceutical company Novo Nordisk has officially launched its once-weekly injectable weight management drug, Wegovy® (semaglutide 2.4mg), in Singapore. The treatment received regulatory ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
A long-term investor in Apple (AAPL) might be perfectly thrilled at the stock's performance. It has returned 663% over the past 10 years, compared with a return of 261% for the S&P 500 SPX. And ...
When Amy Schumer realized Ozempic and Wegovy had harmful side effects for her, she didn’t let that deter her from trying other prescriptions to lose ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...